Medigene
Pre-clinicalMedigene is a biotechnology company focused on developing T-cell immunotherapies for the treatment of cancer.
Founded
1994
Focus
BiologicsCell & Gene Therapy
About
Medigene is a biotechnology company focused on developing T-cell immunotherapies for the treatment of cancer.
Funding History
2IPOUndisclosedUndisclosedJun 15, 2000
Series AUndisclosedUndisclosedJun 15, 1994
Company Info
TypePrivate
Founded1994
LocationPlanegg, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile